title: [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
authors.affiliation: Division of Interventional Radiology of Guangdong General Hospital, Guangdong Academy of Medical Science, Guangzhou 510080, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
authors.forename: Jian-wen
authors.initials: JW
authors.lastname: Huang
authors.forename: Li-gong
authors.initials: LG
authors.lastname: Lu
authors.forename: Pei-jian
authors.initials: PJ
authors.lastname: Shao
authors.forename: Bao-shan
authors.initials: BS
authors.lastname: Hu
authors.forename: Guo-min
authors.initials: GM
authors.lastname: Huang
authors.forename: Zhao-guang
authors.initials: ZG
authors.lastname: Wei
authors.forename: Lei
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D000077157:Sorafenib; D015996:Survival Rate; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib